Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
01/29/2004 | DE10231587A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
01/29/2004 | CA2851035A1 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
01/29/2004 | CA2493258A1 Synthesis of oligosaccharides, glycolipids, and glycoproteins using bacterial clycosyltransferases |
01/29/2004 | CA2493007A1 Protein complexes of the tip60 transcriptional activator protein |
01/29/2004 | CA2492838A1 Process for producing cmp-n-acetylneuraminic acid |
01/29/2004 | CA2492784A1 Method for obtaining pathogen resistance in plants by double-stranded rna gene silencing of nadph oxidase |
01/29/2004 | CA2492407A1 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
01/28/2004 | EP1384776A1 Genes encoding proteins participating in cytokinin synthesis |
01/28/2004 | EP1383914A2 Improved method for detection of atp |
01/28/2004 | EP1383908A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/28/2004 | EP1383907A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
01/28/2004 | EP1383902A2 Overexpression of phosphoenolpyruvate carboxylase |
01/28/2004 | EP1383899A2 Enzymatic method for the enantioselective reduction of keto compounds |
01/28/2004 | EP1383897A2 Self-containing lactococcus strain |
01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
01/28/2004 | EP1383890A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
01/28/2004 | EP1383886A2 D-hydantoinase from ochrobactrum anthropi |
01/28/2004 | EP1383885A1 Method of preparation of stabilized thrombin-activatable fibrinolysis inhibitor (tafi) and methods of use thereof |
01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
01/28/2004 | EP1383882A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
01/28/2004 | EP1383881A2 Lipolytic enzymes from strains of fusarium and acremonium |
01/28/2004 | EP1383880A1 Novel human kinase and polynucleotides encoding the same |
01/28/2004 | EP1383879A1 Novel human kinases and polynucleotides encoding the same |
01/28/2004 | EP1383878A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/28/2004 | EP1383877A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/28/2004 | EP1383876A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/28/2004 | EP1383875A2 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof |
01/28/2004 | EP1383874A1 Variants of lipoxygenase and their use |
01/28/2004 | EP1383873A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/28/2004 | EP1383871A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/28/2004 | EP1383865A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
01/28/2004 | EP1383788A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
01/28/2004 | EP1383782A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
01/28/2004 | EP1383781A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
01/28/2004 | EP1383540A2 Methods and pharmaceutical compositions for healing wounds |
01/28/2004 | EP1383528A2 Epitope sequences |
01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
01/28/2004 | CN1471582A Methods for producing a polypeptide using a consensus translational initiator sequence |
01/28/2004 | CN1471577A Transgenic plants containing molecular decoys that alter protein content therein |
01/28/2004 | CN1471576A Immortalized preosteoblasts and method for their production |
01/28/2004 | CN1471528A Pyrrolidine derivatives and their use as chymase inhibitor |
01/28/2004 | CN1470634A Enterpeptidase light chain variant with high activity and high stability |
01/28/2004 | CN1136316C Gene encoding endoglyco ceramidase |
01/28/2004 | CN1136315C Purified polyporus laccases and nucleic acids encoding same |
01/28/2004 | CN1136313C Method for immobilizing penicillin amidase by ultrasonic treatment |
01/28/2004 | CN1136312C Modification immobilizing process for elastase and its application method |
01/28/2004 | CN1136311C Subtilase variants and compositions |
01/28/2004 | CN1136310C D-sorbitol dehydrogenase |
01/28/2004 | CN1136309C Malodour-reducing composttion and product and use of oxidation-reduction enzyme for reducing malodour |
01/27/2004 | US6684162 Three dimensional crystal structures of polyketide synthase complexed with domain petides, used for drug screening; antibiotics |
01/27/2004 | US6683232 Production of γ linolenic acid by a Δ6-desaturase |
01/27/2004 | US6683231 High level production of p-hydroxybenzoic acid in green plants |
01/27/2004 | US6683230 Hybrid seed production |
01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
01/27/2004 | US6683165 Human gene relating to respiratory diseases and obesity |
01/27/2004 | US6683060 Chelating zinc with 1-(3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine -2,4(1h,3h)-dione; ovarian cancer |
01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
01/27/2004 | US6683055 Guanidine or amidine termined peptides |
01/27/2004 | US6683054 Use of melagatran |
01/27/2004 | US6682924 Protease variants and compositions |
01/27/2004 | US6682923 Non-naturally occurring xylanase activity (xa) protein; bleaching agent comprising as an active ingredient an xa protein in the bleaching process of pulp and in the food and animal feed industry |
01/27/2004 | US6682922 Polypeptides having phospholipase activity and nucleic acids encoding same |
01/27/2004 | US6682921 Useful for solving the crystal and solution structures of the tyrosine kinase domains and for identifying compounds that bind to domains of receptor and non-receptor tyrosine kinases |
01/27/2004 | US6682920 Compositions and methods for identifying PKB kinase inhibitors |
01/27/2004 | US6682919 Polynucleotide sequence encodes the same mature polypeptide, expressed by the fabh gene contained in staphylococcus aureus |
01/27/2004 | US6682918 Bacterial sucrose synthase compositions and methods of use |
01/27/2004 | US6682917 Rate-limiting enzyme, which converts ribonucleotides to their corresponding deoxyribonucleotides and supplies them for purposes of dna synthesis; drug comprising protein; kit for screening for modulators of protein activity |
01/27/2004 | US6682912 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
01/27/2004 | US6682905 Receptor-type phosphotyrosine phosphatase-alpha |
01/27/2004 | US6682904 Detecting a decrease in hyal2 activity due to contact with the test agent, wherein the test agent does not substantially affect activity of an anti-inflammatory hyaluronidase, thereby identifying an agent that specifically inhibits hyal2 activity |
01/27/2004 | US6682891 Methods of identifying nucleic acid sequences encoding plant riboflavin synthase enzymes |
01/27/2004 | US6682733 Fibrinolytic enzymes |
01/22/2004 | WO2004007750A2 Monooxygenases, nucleic acids encoding them and methods for making and using them |
01/22/2004 | WO2004007744A2 Engineering $g(b)-ketoacyl acp synthase for novel substrate specificity |
01/22/2004 | WO2004007732A1 Cloning and characterization of a lipoxygenase from phaeodactylum tricornutum |
01/22/2004 | WO2004007731A1 Transgenic expression constructs and methods for increasing the vitamin e content in plant organisms |
01/22/2004 | WO2004007728A1 Regulation of human tripeptidyl peptidase ii |
01/22/2004 | WO2004007727A1 Use of a gene for increasing the oil content in plants |
01/22/2004 | WO2004007720A2 Treatment of proliferative disorders |
01/22/2004 | WO2004007714A1 Human prothrombin analog and human meizothrombin analog |
01/22/2004 | WO2004007708A1 Modulation of cytochrome p450 reductase activity |
01/22/2004 | WO2004007707A1 Process for producing a virus-inactivated thrombin preparation |
01/22/2004 | WO2004007706A1 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
01/22/2004 | WO2004007705A1 Nucleotide sequences that encode deregulated phosphoglycerate dehydrogenases of coryneform bacteria and method for producing l-serine |
01/22/2004 | WO2004007704A2 Neuronally expressed tryptophane hydroxylase and its use |
01/22/2004 | WO2004007691A2 Herbicide-resistant plants, and polynucleotides and methods for providing same |
01/22/2004 | WO2004007688A2 Metabolic pathways for starter units in polyketide biosynthesis |
01/22/2004 | WO2004007686A2 Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates |
01/22/2004 | WO2004007684A2 Synthetic tag genes |
01/22/2004 | WO2004007680A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
01/22/2004 | WO2004007670A2 RECOMBINANT TYPE II RESTRICTION ENDONUCLEASES, MmeI AND RELATED ENDONUCLEASES AND METHODS FOR PRODUCTING THE SAME |
01/22/2004 | WO2004007548A1 Use of aspartic proteases in cosmetics and therapeutics |
01/22/2004 | WO2004007541A1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
01/22/2004 | WO2004007512A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |